Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs WellMedr

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and WellMedr head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 438 · Grade C

WellMedr

Visit WellMedr Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 53 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make WellMedr a bad call — it's best for readers who already intend to commit to a full year and want to know exactly what the $59 does and does not include before they do — and readers shopping the microdose line, which is a real eight-product range here rather than a smaller amount of a standard plan. not readers trying to price a single month they can walk away from. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
32
Supply Reliability
95
72
Transparency
90
42
Access Breadth
93
74
Clinical Oversight
92
58
Track Record
88
48
CoreAge RxBrief Score 94 · 53WellMedr

Price, coverage & the tracker

CoreAge RxWellMedr
Brief Score94/100 (A)53/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Not disclosed — the advertised rate is tied to a 12-month plan and no month-to-month price is published

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Not disclosed — no month-to-month price is published; plans bill every 4 weeks

CoverageUS only; restrictions by state, confirmed at intakeCoverage not published
Brand-name accessNot confirmedYes
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

WellMedr: The $59 semaglutide headline is tied to a twelve-month plan; the term behind the $99 tirzepatide headline needs confirmation. Both plans ship every four weeks, so compare the full charge and supply period before paying.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.